HF
FULC icon

HRT Financial’s Fulcrum Therapeutics FULC Stock Holding History

HRT Financial’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-124,924
Closed -$1.15M – 3450
2025
Q3 		$1.15M Buy
+124,924
New +$904K ﹤0.01% 1451
2025
Q2 		– Sell
-50,490
Closed -$145K – 2948
2025
Q1 		$145K Sell
50,490
-17,579
-26% -$64.6K ﹤0.01% 2090
2024
Q4 		$319K Buy
+68,069
New +$251K ﹤0.01% 1681
2024
Q2 		– Sell
-123,408
Closed -$1.16M – 2493
2024
Q1 		$1.16M Buy
+123,408
New +$1.1M 0.01% 814
2022
Q4 		– Sell
-20,857
Closed -$168K – 2687
2022
Q3 		$168K Buy
+20,857
New +$149K ﹤0.01% 2266

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HRT Financial's FULC Position: Q4 2025 in Review

HRT Financial sold out of Fulcrum Therapeutics (FULC) in Q4 2025, closing a stake of 124,924 shares — an estimated $1.15M sold.

HRT Financial first reported a position in FULC in Q3 2022 and held it in 5 quarters. The position peaked at $1.16M in Q1 2024. 172 funds tracked by Wall St. Rank hold FULC as of Q4 2025.

  • HRT Financial reported no remaining Fulcrum Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 124,924 Fulcrum Therapeutics shares in Q4 2025, an estimated $1.15M.
  • HRT Financial first reported a position in Fulcrum Therapeutics in Q3 2022 and held it in 5 quarters.
  • HRT Financial's Fulcrum Therapeutics position peaked at $1.16M in Q1 2024.
  • 172 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.